Published in BMC Neurol on June 01, 2006
Stroke patient outcomes in US hospitals before the start of the Joint Commission Primary Stroke Center certification program. Stroke (2009) 1.78
30-day mortality and readmission after hemorrhagic stroke among Medicare beneficiaries in Joint Commission primary stroke center-certified and noncertified hospitals. Stroke (2011) 1.29
The Lombardia Stroke Unit Registry: 1-year experience of a web-based hospital stroke registry. Neurol Sci (2010) 0.82
Impact of clinical registries on quality of patient care and health outcomes: protocol for a systematic review. BMJ Open (2016) 0.77
Administrative data linkage to evaluate a quality improvement program in acute stroke care, Georgia, 2006-2009. Prev Chronic Dis (2015) 0.75
Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States. BMC Neurol (2013) 0.75
Impact of clinical registries on quality of patient care and clinical outcomes: A systematic review. PLoS One (2017) 0.75
Medscape's response to the Institute of Medicine Report: Crossing the quality chasm: a new health system for the 21st century. MedGenMed (2001) 38.72
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 11.84
Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001. JAMA (2003) 7.90
Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA (2000) 7.25
Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke (2003) 4.13
A qualitative study of increasing beta-blocker use after myocardial infarction: Why do some hospitals succeed? JAMA (2001) 2.90
Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology (2005) 2.81
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation (2005) 2.38
Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J (2004) 2.32
Hospital-level performance improvement: beta-blocker use after acute myocardial infarction. Med Care (2004) 1.10
Quality of care provided by general practitioners using or not using Division-based diabetes registers. Med J Aust (2002) 1.03
What are hospitals doing to increase beta-blocker use? Jt Comm J Qual Saf (2003) 0.87
Updated Primary Stroke Center Certification appendix for the disease-specific care manual. Jt Comm Perspect (2005) 0.83
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med (2013) 8.76
Should the Babinski sign be part of the routine neurologic examination? Neurology (2005) 5.57
Midlife cardiovascular risk factors and risk of dementia in late life. Neurology (2005) 5.12
The beautiful and ethereal neurological exam: an appeal for research. Ann Neurol (2011) 4.10
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke (2005) 3.74
Risk of stroke in children: ethnic and gender disparities. Neurology (2003) 3.47
Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology (2012) 3.20
Global variation in the relative burden of stroke and ischemic heart disease. Circulation (2011) 3.02
Financial anatomy of neuroscience research. Ann Neurol (2006) 2.71
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
NIH disease funding levels and burden of disease. PLoS One (2011) 2.56
Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke (2004) 2.42
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation (2005) 2.38
Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics (2007) 2.29
Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke (2003) 2.28
Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke (2007) 2.26
Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol (2006) 2.17
Influence of physician specialty on outcomes after acute ischemic stroke. J Hosp Med (2008) 2.07
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. Circulation (2008) 2.05
Getting youth in the game: can we accelerate training for clinician-scientists? Ann Neurol (2010) 2.04
Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive. Stroke (2013) 2.01
Recent trauma and acute infection as risk factors for childhood arterial ischemic stroke. Ann Neurol (2012) 1.94
Moyamoya disease in Washington State and California. Neurology (2005) 1.88
Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. Stroke (2008) 1.88
Thirty-year projections for deaths from ischemic stroke in the United States. Stroke (2003) 1.86
Intracranial atherosclerotic disease: an update. Ann Neurol (2009) 1.86
Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke (2011) 1.84
Declining stroke rates in Californian children with sickle cell disease. Blood (2004) 1.83
Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke (2002) 1.80
Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke (2003) 1.78
Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke (2005) 1.78
Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke (2004) 1.74
Predictors and outcomes of intraprocedural rupture in patients treated for ruptured intracranial aneurysms: the CARAT study. Stroke (2008) 1.72
A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke. Stroke (2011) 1.72
Translational research for a new administration: what sort of change to believe in? Ann Neurol (2008) 1.71
Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke (2010) 1.71
Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial. Bull World Health Organ (2009) 1.70
Application of the ABCD2 score to identify cerebrovascular causes of dizziness in the emergency department. Stroke (2012) 1.65
Recruiting subjects for acute stroke trials: a meta-analysis. Stroke (2005) 1.65
Association between major perioperative hemorrhage and stroke or Q-wave myocardial infarction. Circulation (2012) 1.58
Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke (2009) 1.56
Imaging data reveal a higher pediatric stroke incidence than prior US estimates. Stroke (2009) 1.56
Neurological disease on the global agenda. Ann Neurol (2008) 1.56
High critical care usage due to pediatric stroke: results of a population-based study. Neurology (2012) 1.56
Financing of U.S. biomedical research and new drug approvals across therapeutic areas. PLoS One (2009) 1.55
Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol (2010) 1.53
Recurrent hemorrhagic stroke in children: a population-based cohort study. Stroke (2007) 1.51
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease. Eur Heart J (2009) 1.49
The dangers of clinical conviction: an "M&M" of endovascular therapies for stroke. Ann Neurol (2013) 1.48
Why are eligible thrombolysis candidates left untreated? Am J Prev Med (2006) 1.45
Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke (2009) 1.44
4-aminopyridine: new life for an old drug. Ann Neurol (2010) 1.43
Journeys in complex genetics: music and mental illness. Ann Neurol (2009) 1.39
Electronic medical records: does it take a village or a thousand points of light? Ann Neurol (2008) 1.39
That vexing problem of compensation. Ann Neurol (2008) 1.39
Safety and feasibility of a CT protocol for acute stroke: combined CT, CT angiography, and CT perfusion imaging in 53 consecutive patients. AJNR Am J Neuroradiol (2003) 1.37
Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Stroke (2010) 1.35
Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol (2006) 1.33
Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. J Womens Health (Larchmt) (2004) 1.32
Higher ABCD2 score predicts patients most likely to have true transient ischemic attack. Stroke (2008) 1.28
A status report on neuroscience research, without grade inflation. Ann Neurol (2006) 1.24
The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Stroke (2012) 1.24
Effect of presenting hemorrhage on outcome after microsurgical resection of brain arteriovenous malformations. Neurosurgery (2005) 1.22
Profiles of lacunar and nonlacunar stroke. Ann Neurol (2011) 1.19
Basic and clinical research: what is the most appropriate weighting in a public investment portfolio? Ann Neurol (2006) 1.18
How accurate is CT angiography in evaluating intracranial atherosclerotic disease? Stroke (2008) 1.16
External validation of the ICH score. Neurocrit Care (2004) 1.16
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack. Stroke (2012) 1.15
Prevalence and predictors of perinatal hemorrhagic stroke: results from the kaiser pediatric stroke study. Pediatrics (2009) 1.14
The importance of cerebral aneurysms in childhood hemorrhagic stroke: a population-based study. Stroke (2008) 1.13
Cognitive function predicts first-time stroke and heart disease. Neurology (2005) 1.08
Epidemiology of intracranial stenosis. J Neuroimaging (2009) 1.07
Characteristics of brain arteriovenous malformations with coexisting aneurysms: a comparison of two referral centers. Stroke (2002) 1.07
Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization. J Stroke Cerebrovasc Dis (2007) 1.05
Transformative research. Ann Neurol (2008) 1.05
Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation. Neurology (2012) 1.05
Urinary tract infections complicating stroke: mechanisms, consequences, and possible solutions. Stroke (2010) 1.04
Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results. J Neuroimaging (2009) 1.04
Risk of vascular events in emergency department patients discharged home with diagnosis of dizziness or vertigo. Ann Emerg Med (2010) 1.02
Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations. Neurosurgery (2006) 1.01
Prognostic significance of angiographically confirmed large vessel intracranial occlusion in patients presenting with acute brain ischemia. Neurocrit Care (2006) 1.01
Declining diagnosis of birth asphyxia in California: 1991-2000. Pediatrics (2004) 1.00
Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial. Int J Stroke (2011) 1.00
NIH Stroke Scale reliability in ratings from a large sample of clinicians. Cerebrovasc Dis (2006) 0.99
Distinctive RNA expression profiles in blood associated with white matter hyperintensities in brain. Stroke (2010) 0.99
Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event. Stroke (2005) 0.98